These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
742 related articles for article (PubMed ID: 34249086)
1. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer. Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J Front Genet; 2021; 12():661306. PubMed ID: 34249086 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer. Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X Front Oncol; 2021; 11():799223. PubMed ID: 35096599 [TBL] [Abstract][Full Text] [Related]
3. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes. Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791 [No Abstract] [Full Text] [Related]
6. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data. Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111 [TBL] [Abstract][Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H Front Genet; 2022; 13():957655. PubMed ID: 36105100 [No Abstract] [Full Text] [Related]
9. An Han Y; Wong FC; Wang D; Kahlert C Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555 [TBL] [Abstract][Full Text] [Related]
10. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer. Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672 [No Abstract] [Full Text] [Related]
11. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Wu M; Li X; Zhang T; Liu Z; Zhao Y Front Oncol; 2019; 9():996. PubMed ID: 31612115 [No Abstract] [Full Text] [Related]
12. Identification of an EMT-related gene-based prognostic signature in osteosarcoma. Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261 [TBL] [Abstract][Full Text] [Related]
13. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related]
14. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients. Zhu G; Xia H; Tang Q; Bi F Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026 [TBL] [Abstract][Full Text] [Related]
15. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X Front Immunol; 2021; 12():651033. PubMed ID: 34054812 [TBL] [Abstract][Full Text] [Related]
16. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. Yang F; Zhou LQ; Yang HW; Wang YJ Front Genet; 2022; 13():927614. PubMed ID: 36092911 [No Abstract] [Full Text] [Related]
17. Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients. Zhou L; Chen Z; Wu Y; Lu H; Xin L Cancer Cell Int; 2021 Jul; 21(1):357. PubMed ID: 34233659 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes. Zheng J; Dong H; Zhang T; Ning J; Xu Y; Cai C Front Genet; 2022; 13():865052. PubMed ID: 35559024 [No Abstract] [Full Text] [Related]
19. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
20. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients. Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]